Found 1,117 investors
Paragon Biosciences
United States
Paragon Biosciences is an incubator and investor that builds and grows biotechnology firms. The firm connects their firms with entrepreneurs and clinical experts to provide the strategy, guidance and support they need to ensure important medicines reach patients.
Accelerator
Incubator
Participex Gestion
France
Founded in 1980, Participex Gestion was a private equity arm of Crédit Agricole Nord de France and was based in Lille, France. The firm primarily used to invest in the metals and mining, energy, construction and engineering, commercial services, hotels, restaurants, media, distribution, information and communication technology, biotechnology and real estate sectors. It was acquired by Vauban Partenaires in 2005.
Private Equity Firm
Pascal Mercier
United States
Dr. Eugene Hsu is an Angel Investor. Dr. Eugene Hsu also served as Chief Medical Officer at Vim. He also served as Board Member and Vice-President of Strategy at Video Medicine. He is a physician innovator who is passionate about applying technology to the challenge of improving human health. He is a board certified anesthesiologist who trained at the Johns Hopkins Hospital where he remains on the faculty as an Adjunct Assistant Professor. Eugene is also board certified in Medical Quality and completed a fellowship in Patient Safety and Quality at the Armstrong Institute for Patient Safety and Quality at Johns Hopkins. He has over a dozen peer-reviewed publications including citation by the New York Times, worked at the Centers for Medicare and Medicaid Innovation Center, Johnson & Johnson Development Corporation, The Monitor Group and 3V SourceOne Venture Capital. In addition, Eugene has been an integral part of several startup companies in biotechnology, and information technology. He completed his undergraduate studies at Duke University and his graduate training in medicine and business administration at Dartmouth Medical School. Eugene is fluent in Mandarin Chinese and Spanish, and proficient in Japanese and has traveled to over 30 countries and 6 continents.
Individual/Angel
Pathway Bioventures
United States
Founded in 2018, Pathway Bioventures is a venture capital firm based in Chicago, Illinois. The firm prefers to invest in seed-stage and early-stage companies operating in the life sciences, biotechnology, pharmaceutical, and medical device sectors.
Venture Capital
Patrick de Picciotto
New York, New York
Co-Founder and Partner at Canary
Consumer Internet
Enterprise
Patriot Capital
Baltimore, Maryland, United States
Patriot Capital provides debt and equity capital in acquisitions, management buyouts and recapitalizations.
Private Equity Firm
Patriot Capital Funding
Westport, Connecticut, United States
Patriot Capital Funding, Inc. (Nasdaq symbol: PCAP) is a publicly traded, specialty finance company that provides customized financing
Private Equity Firm
Patriot Financial Partners
Philadelphia, Pennsylvania, United States
Patriot Financial Partners is a private equity firm focused on investing in community banks, thrifts and financial services.
Financial Services
Private Equity Firm
Patriot Growth Partners
United States
founded in 2016, Patriot Growth Partners is a private equity investment firm based in Washington, Pennsylvania. The firm specializes in growth investments and buyout transactions. It prefers to invest in companies operating in the business, consumer products and services, financial services across the United States and the United Kingdom.
Private Equity Firm
Paul Devlin
New York, New York, United States
Head of Commercialisation at Heriot-Watt University
Individual/Angel
Paul McArdle
United States
InterWest Healthcare Partners is a venture capital arm of InterWest Partners based in Menlo Park, California. The firm seeks to invest in the healthcare, biotechnology, pharmaceutical, healthcare IT, personalized medicines, and medical device sectors.
Venture Capital
Paul Scheuschner
United States
Mr. Jay Flatley serves as Chief Executive Officer and Chairman at Zymergen. While serving as Chief Executive Officer he has served on the Board since January 2020 and has served as Chairperson since April 2021. He served as Board Member at Helix. From December 2013 through July 2016, he served as the Chief Executive Officer of Illumina, Inc. (Illumina), a public company focused on sequencing and array-based solutions for genetic analysis, and from October 1999 through December 2013, he served as the President and Chief Executive Officer of Illumina. Prior to joining Illumina, he co-founded and served as President, Chief Executive Officer, and Director of Molecular Dynamics, a life sciences company focused on genetic discovery and analysis, from 1994 until its sale to Amersham Pharmacia Biotech in 1998. He also served on the board of directors of Illumina from 1999 through May 2021, as the Executive Chair of Illumina from July 2016 through January 2020, and as the Chairman of the Board of Illumina from January 2020 through May 2021. He has also served on the board of directors of Denali Therapeutics Inc., a public biotechnology company, since 2015, and Coherent Inc., a publicly-traded photonics manufacturing company, since 2011; he previously served on the board of directors of Juno Therapeutics, Inc., from 2017 to 2018. He is an advisory board member for U.C. San Diego's Moore Cancer Centre and serves on the board of trustees of the Salk Institute for Biological Studies. He also serves as Advisor at Illumina Ventures.
Individual/Angel
PB Invest
Poland
PB Invest was a Warsaw, Poland based venture capital firm. It invested in the pharmaceutical and biotechnology sectors.
Venture Capital
Penang i4.0 Seed Fund
Malaysia
Founder in 2018, Penang i4.0 Seed Fund is a venture capital firm based in Penang, Malaysia. The firm is a special seed program initiated by the Penang State Government to fund the early-stage technology companies operating in the internet of things (IoT), advanced manufacturing, consumer digital, EdTech, enterprise tech, cleantech, and Medtech sectors.
Venture Capital
Perpetua Investment Group
United Kingdom
Perpetua Investment Group is a hedge fund investment firm headquartered in London, United Kingdom with a regional office based in Luxembourg, Europe. The firm seeks to invest through private placements, straight equity or convertible bonds in companies based in Europe, Australia, and Asia, across life sciences, mining, software, energy, and biotechnology sectors.
Hedge Fund
Peter Van Dorn
United States
Mr. Patrick Lilley serves as Board Member & Executive at BlueprintBio. He served as the Chief Executive Officer, President and Board Member at Emerald Logic. He is the Board Member at BlueprintBio. He was the Financial Analyst at AST Computers. Patrick was the Chief Executive Officer and Founder of Emerald Logic. Patrick has spent the last 25 years driving growth and innovation in biotech, software, high-performance computing, and mobile wireless. He has produced or participated in several high-value startups Digital Transit, Bitfone, Esmertec and Datallegro totaling over $400M. He holds patents in artificial intelligence, disease prognosis, and specialized algorithms. He has guest lectured at the California Institute of Technology, Massachusetts Institute of Technology, Stanford University, University of Southern California, and University of California, Irvine. He holds a B.A. in Economics and a masters degree in business administration specializing in quantitative finance, both from University of California, Irvine.
Individual/Angel
PharmaBio Development
United States
Founded in 2011, PharmaBio Development is a private equity firm based in Raleigh, North Carolina. The firm seeks to invest in the life sciences, pharmaceuticals, and biotechnology sectors.
Private Equity Firm
Philippe Nore
Palo Alto, California, United States
Vice President at Adaptive Biotechnologies Corp.
Individual/Angel
PHL Venture Company
United States
PHL Venture Company is a holding company with diversified assets in the technology, media, biotech, energy, finance, lifestyle and real estate sectors. The firm has invested in over 150 assets, with the majority of focus in the public markets. It was founded in 2015 and is based in Burbank, California.
Venture Capital
Showing 821 to
840 of
1,117 results